Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
Key facts
- Who runs it
- Insel Gruppe AG, University Hospital Bern
- Where
- Switzerland4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 170 people enrolled
- Started
- 19 Jul 2021
- Ended
- 7 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Fluid management according to the REDUCE Fluid Protocol
- Standard of care
- Record updated
- 5 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients admitted to ICU with the diagnosis of septic shock as defined according to the Sepsis-3 criteria (suspected or confirmed infection AND vasopressor/inotrope ongoing to maintain MAP ≥ 65 mmHg AND Lactate ≥ 2 mmol/l in the last 6 hours
Who cannot take part
- Patients that are known to be allergic to furosemide or metolazone
- Age <18 years
- Septic shock for more than 12 hours at the time of screening
- Acute burn injury >/= 10% of the body surface area
- Known pregnancy or lactating women
- Consent not obtainable due to national legislation
- Patients on chronic dialysis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Recent studies have questioned the safety of current fluid resuscitation strategies in patients with septic shock as prospective and observational data suggesting that the resulting fluid overload is associated with mortality. Two strategies have evolved to prevent or minimize fluid overload: restrictive fluid administration or active removal of accumulated fluid. While several small trials show benefits with a restrictive fluid administration regimen, active protocolized de-resuscitation was scarcely evaluated. The combination of both strategies yet warrants systematic evaluation.
Read full original descriptionShow less
Aim: This study aims to assess the efficacy and feasibility of an early active de-resuscitation protocol in patients with septic shock. We hypothesize that the application of a structured early de-resuscitation protocol versus standard of care will lead to less fluid overload at day three after ICU admission.
Study Intervention: Patients admitted to the ICU with confirmed or suspected septic shock (Sepsis-3 definition) will be randomized (1:1) to either the intervention or standard of care. In the intervention arm, patients are managed according to the REDUCE fluid management protocol during resuscitation and de-resuscitation.
The 2 groups in the trial
- Intervention: REDUCE ProtocolTreatment being tested
Fluid resuscitation and de-resuscitation is based on the REDUCE fluid management protocol.
Treatment: Fluid management according to the REDUCE Fluid Protocol
- Standard of CareExisting treatment, for comparison
Fluid resuscitation and de-resuscitation according to the standard of care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Protocolised Early De-Resuscitation in Septic Shock (REDUCE) - a Randomised Controlled Multi-centre Feasibility Study
- Publications
- Record updated
- 5 May 2026